+

WO2001098747A3 - Agonist versus antagonist binding to g protein-coupled receptors - Google Patents

Agonist versus antagonist binding to g protein-coupled receptors Download PDF

Info

Publication number
WO2001098747A3
WO2001098747A3 PCT/US2001/019871 US0119871W WO0198747A3 WO 2001098747 A3 WO2001098747 A3 WO 2001098747A3 US 0119871 W US0119871 W US 0119871W WO 0198747 A3 WO0198747 A3 WO 0198747A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding
agonist
protein
coupled receptors
molecular
Prior art date
Application number
PCT/US2001/019871
Other languages
French (fr)
Other versions
WO2001098747A2 (en
Inventor
Zdzislaw Salamon
Scott Cowell
Victor J Hruby
Gordon Tollin
Original Assignee
Univ Arizona
Zdzislaw Salamon
Scott Cowell
Victor J Hruby
Gordon Tollin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona, Zdzislaw Salamon, Scott Cowell, Victor J Hruby, Gordon Tollin filed Critical Univ Arizona
Priority to JP2002504459A priority Critical patent/JP2004507716A/en
Priority to AU2001270046A priority patent/AU2001270046A1/en
Priority to EP01948579A priority patent/EP1295120A2/en
Priority to CA002413081A priority patent/CA2413081A1/en
Publication of WO2001098747A2 publication Critical patent/WO2001098747A2/en
Publication of WO2001098747A3 publication Critical patent/WO2001098747A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method of characterizing the biophysical properties of G protein-coupled receptors in response to binding by ligands. The clone human δopioid receptor immobilized in a solid-supported lipid bilayer was investigated by a method featuring coupled plasmon-waveguide resonance (CPWR) spectroscopy. The invention offers a highly sensitive method that directly monitors mass density, conformation, and molecular orientation changes occurring in anisotropic thin films, and allows direct determination of binding constants. Although both agonist and antagonist binding to the receptor cause increases in molecular ordering within the proteolipid membrane, only agonist binding induces an increase in thickness and molecular packing density of the membrane (10). This provides a method of discriminating between agonist and antagonist binding.
PCT/US2001/019871 2000-06-22 2001-06-21 Agonist versus antagonist binding to g protein-coupled receptors WO2001098747A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2002504459A JP2004507716A (en) 2000-06-22 2001-06-21 Methods for distinguishing agonists and antagonists of G protein-coupled receptors
AU2001270046A AU2001270046A1 (en) 2000-06-22 2001-06-21 Agonist versus antagonist binding to g protein-coupled receptors
EP01948579A EP1295120A2 (en) 2000-06-22 2001-06-21 Agonist versus antagonist binding to g protein-coupled receptors
CA002413081A CA2413081A1 (en) 2000-06-22 2001-06-21 Agonist versus antagonist binding to g protein-coupled receptors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21357500P 2000-06-22 2000-06-22
US60/213,575 2000-06-22

Publications (2)

Publication Number Publication Date
WO2001098747A2 WO2001098747A2 (en) 2001-12-27
WO2001098747A3 true WO2001098747A3 (en) 2002-04-11

Family

ID=22795635

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/019871 WO2001098747A2 (en) 2000-06-22 2001-06-21 Agonist versus antagonist binding to g protein-coupled receptors

Country Status (5)

Country Link
EP (1) EP1295120A2 (en)
JP (1) JP2004507716A (en)
AU (1) AU2001270046A1 (en)
CA (1) CA2413081A1 (en)
WO (1) WO2001098747A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030006192A1 (en) * 1998-02-23 2003-01-09 Irving Wainer Immobilized G-protein coupled receptors on liquid chromatography stationary phases and use thereof for on-line screening
US7678539B2 (en) * 2000-08-10 2010-03-16 Corning Incorporated Arrays of biological membranes and methods and use thereof
US20160334395A1 (en) * 2014-01-21 2016-11-17 Nanyang Technological University Hydration layer/lipid bilayer structures

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5991448A (en) * 1994-10-28 1999-11-23 Oki Electric Industry Co., Ltd. Image encoding and decoding method and apparatus using edge synthesis and inverse wavelet transform

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5991448A (en) * 1994-10-28 1999-11-23 Oki Electric Industry Co., Ltd. Image encoding and decoding method and apparatus using edge synthesis and inverse wavelet transform

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BEIRI ET AL.: "Micropatterned immobilization of G protein-coupled receptor: and direct detection of G protein activation", NAT. BIOTECHNOL., vol. 17, November 1999 (1999-11-01), pages 1105 - 1108, XP002183971 *
SALAMON ET AL.: "Coupled plasmon-waveguide resonators: A new spectroscopis tool for probing proteolipid film structure and properties", BIOPHYS. J., vol. 75, October 1998 (1998-10-01), pages 1874 - 1885, XP002906545 *
SLEPAK V.Z.: "Application of surface plasmon resonance for analysis of protein-protein interactions in the G protein-mediated signal transduction pathway", J. MOL. RECOGNIT., vol. 13, January 2000 (2000-01-01), pages 20 - 26, XP002906134 *

Also Published As

Publication number Publication date
CA2413081A1 (en) 2001-12-27
WO2001098747A2 (en) 2001-12-27
JP2004507716A (en) 2004-03-11
EP1295120A2 (en) 2003-03-26
AU2001270046A1 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
WO2001077172A3 (en) Non-endogenous, constitutively activated known g protein-coupled receptors
WO2001036471A3 (en) Endogenous and non-endogenous versions of human g protein-coupled receptors
EP1477880A3 (en) Secure browser
MX2009005963A (en) Human antibodies to human delta like ligand 4.
WO2003040309A3 (en) Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
WO2004104759A3 (en) Methods and systems for image sharing over a network
HK1107012A1 (en) Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof
WO2001098747A3 (en) Agonist versus antagonist binding to g protein-coupled receptors
AU3080499A (en) Analgesic combination comprising nmda receptor antagonists and narcotic analgesics
CA2019559A1 (en) Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof
CA2305810A1 (en) Methods of assaying receptor activity and constructs useful in such methods
WO1996029315A3 (en) Imidazole derivatives as histamine receptor h3 (ant)agonists
WO1998051329A1 (en) Cachexia remedy
PT1133559E (en) PROTEIN ACOPLATE RECEPTOR G ORFAO HUMAN, RUP3
GB2427945A (en) Data compression methods and systems
EP2579496A3 (en) Displaying a security element with a browser window
WO2003025137A3 (en) Sweet taste receptors
WO2001015014A3 (en) A system and method for advanced network viewing
WO2005091839A3 (en) Methods and apparatuses to cancel query
TW200821208A (en) Sensor device
WO2002100350A3 (en) Dopamine receptor ligands and therapeutic methods based thereon
WO2002059082A8 (en) Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
CN100375527C8 (en) Improvements in and related to content selection
WO2003098397A3 (en) Method and apparatus for determining layer thickness and composition using ellipsometric evaluation
Ichikawa et al. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated [35S] GTPγS binding to mouse brain

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2413081

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 504459

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001948579

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001948579

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001948579

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载